Benzinga
Benzinga
Actualités France
Bourse
Economie
Général
Actualités Américaines
Bourse
Bénéfices
Economie
Marchés prédictifs
Marchés privés
Autres marchés
Recommandations des analystes
Trading
Communiqués de presse
Mondial
Asie
Crypto-monnaies
Actualités cryptos
Altcoins
Bitcoin
Dogecoin
Ethereum
Shiba Inu
NFT
Éducation
Investir en crypto
Investir en bourse
Forex
Benzinga
lundi, octobre 26
Actualités France
Bourse
Economie
Général
Actualités Américaines
Bourse
Bénéfices
Economie
Marchés prédictifs
Marchés privés
Autres marchés
Recommandations des analystes
Trading
Communiqués de presse
Mondial
Asie
Crypto-monnaies
Actualités cryptos
Altcoins
Bitcoin
Dogecoin
Ethereum
Shiba Inu
NFT
Éducation
Investir en crypto
Investir en bourse
Forex
Kairos Pharma Ltd
KAPA
AMEX
Liste de surveillance
Get Report
Trade with Public
Get Report
Trade with Public
$0.5585
0.0145
2.67%
Get Report
Aperçu
Actualités
Prévisions de résultats
Événements
Objectifs de cours
Données financières
Sentiment
Actionnariat
Comparer
Rapport sur les stocks
Kairos Pharma Financials
Kairos Pharma (KAPA) financial statements — income, revenue, gross margin and key metrics.
Earnings & Guidance News
Stock Market Today: S&P 500, Nasdaq 100 Futures Slip Ahead of Data-Heavy Week, Nvidia Earnings, and Jackson Hole—BABA, PMI, BIRK in Focus
U.S. stock futures were mixed on Monday, as the Dow Jones index rose, the S&P 500 and Nasdaq 100 indices fell, after Friday's higher close.
Rishabh Mishra
Applied Optoelectronics, PDD Holdings And 3 Stocks To Watch Heading Into Monday
U.S. stock futures up, PDD, AAOI, and XPEV to report earnings, KAPA announces reverse stock split, GRRR expected to post earnings after close.
Avi Kapoor
PRO
Kairos Pharma Q4 EPS $(0.07) Beats $(0.10) Estimate
Kairos Pharma (AMEX:KAPA) reported quarterly losses of $(0.07) per share which beat the analyst consensus estimate of $(0.10) by 30 percent. This is a 12.5 percent increase over losses of $(0.08) per share from the same
Benzinga Newsdesk
PRO
Kairos Pharma Q2 EPS $(0.08) Misses $(0.05) Estimate
Kairos Pharma (AMEX:KAPA) reported quarterly losses of $(0.08) per share which missed the analyst consensus estimate of $(0.05) by 60 percent.
Benzinga Newsdesk
Nasdaq Gains Over 100 Points; Wells Fargo Earnings Top Views
Avi Kapoor
PRO
Kairos Pharma Q1 EPS $(0.08) Misses $(0.05) Estimate
Kairos Pharma (AMEX:KAPA) reported quarterly losses of $(0.08) per share which missed the analyst consensus estimate of $(0.05) by 60 percent.
Benzinga Newsdesk
